Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Optimized sampling conditions for fecal volatile organic compounds analysis by means of field asymmetric ion mobility spectrometry

Tools
- Tools
+ Tools

Bosch, Sofie, el Manouni el Hassani, Sofia, Covington, James A., Wicaksono, Alfian, Bomers, Marije K., Benninga, Marc A., Mulder, Chris J. J., de Boer, Nanne K. H and de Meij, Tim G. J. (2018) Optimized sampling conditions for fecal volatile organic compounds analysis by means of field asymmetric ion mobility spectrometry. Analytical Chemistry, 90 (13). pp. 7972-7981. doi:10.1021/acs.analchem.8b00688 ISSN 1520-6882.

[img]
Preview
PDF
WRAP-optimized-fecal-volatile-asymmetric-ion-spectrometry-Covington-2018.pdf - Accepted Version - Requires a PDF viewer.

Download (1330Kb) | Preview
Official URL: http://dx.doi.org/10.1021/acs.analchem.8b00688

Request Changes to record.

Abstract

Background Fecal volatile organic compounds (VOCs) are increasingly considered as potential non-invasive, diagnostic biomarkers for various gastrointestinal diseases. Knowledge of influence of sampling conditions on VOC outcomes is limited. We aimed to evaluate effects of sampling conditions on fecal VOC profiles and to assess under which conditions an optimal diagnostic accuracy in the discrimination between pediatric inflammatory bowel disease (IBD) and controls could be obtained. Methods Fecal samples from de novo treatment-naïve pediatric IBD patients and healthy controls (HC) were used to assess effects of sampling conditions compared to the standard operating procedure (reference standard), defined as 500mg of sample mass, diluted with 10mL tap water, using field asymmetric ion mobility spectrometry (FAIMS). Results A total of 17 IBD (15CD and 2 UC) and 25 HC were included. IBD and HC could be discriminated with high accuracy (accuracy=0.93, AUC=0.99, p<0.0001). Smaller fecal sample mass resulted in a decreased diagnostic accuracy (300mg accuracy=0.77; AUC=0.69, p=0.02; 100mg accuracy=0.70, AUC=0.74, p=0.003). A loss of diagnostic accuracy was seen towards increased numbers of thaw-freeze cycles (one cycle: accuracy=0.61, AUC=0.80, p=0.0004, two cycles: accuracy=0.64, AUC=0.56, p=0.753, three cycles: accuracy=0.57, AUC=0.50, p=0.5101) and when samples were kept at room temperature for 180 minutes prior to analysis (accuracy=0.60, AUC=0.51, p=0.46). Diagnostic accuracy of VOC profiles was not significantly influenced by storage duration differences of 20 months. Conclusion Application of 500mg sample mass analyzed after one thaw-freeze cycle, showed best discriminative accuracy for differentiation of IBD and HC. VOC profiles and diagnostic accuracy were significantly affected by sampling conditions, underlining the need for implementation of standardized protocols in fecal VOC analysis.

Item Type: Journal Article
Subjects: Q Science > QD Chemistry
Divisions: Faculty of Science, Engineering and Medicine > Engineering > Engineering
Library of Congress Subject Headings (LCSH): Chemistry, Organic, Organic compounds, Field ionization mass spectrometry
Journal or Publication Title: Analytical Chemistry
Publisher: American Chemical Society
ISSN: 1520-6882
Official Date: 3 July 2018
Dates:
DateEvent
3 July 2018Published
3 June 2018Available
3 June 2018Accepted
Volume: 90
Number: 13
Page Range: pp. 7972-7981
DOI: 10.1021/acs.analchem.8b00688
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 6 June 2018
Date of first compliant Open Access: 3 June 2019
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
UNSPECIFIEDTeva Pharmaceutical Industrieshttp://dx.doi.org/10.13039/100006259
UNSPECIFIEDDr. Ralph and Marian Falk Medical Research Trusthttp://dx.doi.org/10.13039/100008590
UNSPECIFIEDTakeda Pharmaceutical Companyhttp://dx.doi.org/10.13039/100008373
UNSPECIFIEDDanonehttp://dx.doi.org/10.13039/100007773

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us